Deborah Williamson

Summary

Country: New Zealand

Publications

  1. doi Seroprevalence of measles antibodies among high-risk healthcare workers in Auckland, New Zealand: additional justification for assumption of age-determined immunity based on local data
    Deborah Williamson
    Departments of Virology and Immunology, LabPlus, Auckland City Hospital, Auckland, New Zealand
    Infect Control Hosp Epidemiol 31:1082-4. 2010
  2. pmc Population-based incidence and comparative demographics of community-associated and healthcare-associated Escherichia coli bloodstream infection in Auckland, New Zealand, 2005-2011
    Deborah A Williamson
    Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
    BMC Infect Dis 13:385. 2013
  3. doi Increasing incidence and sociodemographic variation in community-onset Staphylococcus aureus skin and soft tissue infections in New Zealand children
    Deborah A Williamson
    Department of Clinical Microbiology, Auckland City Hospital, Auckland, New Zealand
    Pediatr Infect Dis J 32:923-5. 2013
  4. doi Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli
    Deborah A Williamson
    Faculty of Medical and Health Sciences, University of Auckland, New Zealand
    Clin Infect Dis 57:267-74. 2013
  5. pmc Clinical and molecular epidemiology of methicillin-resistant Staphylococcus aureus in New Zealand: rapid emergence of sequence type 5 (ST5)-SCCmec-IV as the dominant community-associated MRSA clone
    Deborah A Williamson
    Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
    PLoS ONE 8:e62020. 2013
  6. doi Improved detection of toxigenic Clostridium difficile using the Cepheid Xpert C difficile assay and impact on C difficile infection rates in a tertiary hospital: a double-edged sword
    Deborah A Williamson
    Department of Clinical Microbiology, Auckland District Health Board, Auckland, New Zealand
    Am J Infect Control 41:270-2. 2013
  7. doi An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis
    Deborah A Williamson
    Department of Clinical Microbiology, Auckland District Health Board, Auckland, New Zealand
    Diagn Microbiol Infect Dis 74:207-9. 2012
  8. doi Identification and molecular characterisation of New Delhi metallo-β-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals
    Deborah A Williamson
    Department of Clinical Microbiology, Auckland District Health Board, Park Road, Grafton, Auckland, New Zealand
    Int J Antimicrob Agents 39:529-33. 2012
  9. doi Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen
    Deborah A Williamson
    Department of Microbiology, Auckland District Health Board, New Zealand
    Clin Infect Dis 54:1406-12. 2012
  10. doi Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis
    D A Williamson
    Department of Clinical Microbiology, Auckland City Hospital, Auckland, New Zealand
    Int J Tuberc Lung Dis 16:216-20. 2012

Detail Information

Publications13

  1. doi Seroprevalence of measles antibodies among high-risk healthcare workers in Auckland, New Zealand: additional justification for assumption of age-determined immunity based on local data
    Deborah Williamson
    Departments of Virology and Immunology, LabPlus, Auckland City Hospital, Auckland, New Zealand
    Infect Control Hosp Epidemiol 31:1082-4. 2010
    ..Some studies suggest that age-specific immunity cannot be assumed. In our local setting, however, we found that 893 (98%) of 912 healthcare workers more than 40 years old tested seropositive for measles immunoglobulin G...
  2. pmc Population-based incidence and comparative demographics of community-associated and healthcare-associated Escherichia coli bloodstream infection in Auckland, New Zealand, 2005-2011
    Deborah A Williamson
    Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
    BMC Infect Dis 13:385. 2013
    ..Against this background, we performed a retrospective, population-based observational study of all cases of E. coli bacteremia in patients presenting to our hospital between January 2005 and December 2011...
  3. doi Increasing incidence and sociodemographic variation in community-onset Staphylococcus aureus skin and soft tissue infections in New Zealand children
    Deborah A Williamson
    Department of Clinical Microbiology, Auckland City Hospital, Auckland, New Zealand
    Pediatr Infect Dis J 32:923-5. 2013
    ..A total of 1860 children were included. There was significant sociodemographic disparity, with the incidence disproportionately higher in Maori and Pacific Island children residing in deprived areas. ..
  4. doi Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli
    Deborah A Williamson
    Faculty of Medical and Health Sciences, University of Auckland, New Zealand
    Clin Infect Dis 57:267-74. 2013
    ..Against this background, we provide an overview of the epidemiology, prevention, and treatment of infectious complications following TRUS biopsy, in the wider context of increasing global antimicrobial resistance. ..
  5. pmc Clinical and molecular epidemiology of methicillin-resistant Staphylococcus aureus in New Zealand: rapid emergence of sequence type 5 (ST5)-SCCmec-IV as the dominant community-associated MRSA clone
    Deborah A Williamson
    Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
    PLoS ONE 8:e62020. 2013
    ..Ongoing molecular surveillance is essential to prevent these MRSA strains becoming endemic in the New Zealand healthcare setting...
  6. doi Improved detection of toxigenic Clostridium difficile using the Cepheid Xpert C difficile assay and impact on C difficile infection rates in a tertiary hospital: a double-edged sword
    Deborah A Williamson
    Department of Clinical Microbiology, Auckland District Health Board, Auckland, New Zealand
    Am J Infect Control 41:270-2. 2013
    ..This led to an abrupt 70% increase in the overall rate of C difficile infection in our institution...
  7. doi An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis
    Deborah A Williamson
    Department of Clinical Microbiology, Auckland District Health Board, Auckland, New Zealand
    Diagn Microbiol Infect Dis 74:207-9. 2012
    ..Using culture as the gold standard, we found that the assay had 100% sensitivity and specificity for detecting M. tuberculosis. However, we found that the assay incorrectly assigned rifampicin resistance in 4/13 (31%) of cases...
  8. doi Identification and molecular characterisation of New Delhi metallo-β-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals
    Deborah A Williamson
    Department of Clinical Microbiology, Auckland District Health Board, Park Road, Grafton, Auckland, New Zealand
    Int J Antimicrob Agents 39:529-33. 2012
    ....
  9. doi Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen
    Deborah A Williamson
    Department of Microbiology, Auckland District Health Board, New Zealand
    Clin Infect Dis 54:1406-12. 2012
    ..In the context of increasing fluoroquinolone resistance, and the international emergence of fluoroquinolone-resistant sequence type 131 (ST131) Escherichia coli, we describe a large series of E. coli bacteremia after TRUS biopsy...
  10. doi Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis
    D A Williamson
    Department of Clinical Microbiology, Auckland City Hospital, Auckland, New Zealand
    Int J Tuberc Lung Dis 16:216-20. 2012
    ..Recently, Mycobacterium tuberculosis isolates have been described that test phenotypically susceptible to rifampicin (RMP) yet harbour genotypic rpoB mutations...
  11. ncbi A case of tricuspid valve endocarditis due to Burkholderia cepacia complex
    Deborah A Williamson
    Department of Microbiology, Auckland District Health Board, Auckland, New Zealand
    N Z Med J 124:84-6. 2011
    ..We describe a case of tricuspid valve endocarditis secondary to B. cepacia complex in an injecting intravenous drug user in Auckland, New Zealand...
  12. doi Distribution of HPV genotypes in women with cervical cancer in Auckland, New Zealand; a review of 50 specimens between 2000-2006
    Deborah Williamson
    Department of Virology and Immunology, Auckland City Hospital, Auckland, New Zealand
    Aust N Z J Obstet Gynaecol 51:67-70. 2011
    ..In New Zealand, around two hundred women are diagnosed with cervical cancer annually, with approximately seventy deaths from cervical cancer per year...
  13. doi A case of infection caused by the basidiomycete Phellinus undulatus
    Deborah Williamson
    1Department of Microbiology, LabPlus, Auckland City Hospital, Auckland, New Zealand
    J Med Microbiol 60:256-8. 2011
    ..Definitive identification was only possible through molecular analysis as the isolate failed to produce any distinct morphological features in vitro...